EHA 2017 | Key topics on AML at EHA 2017

Name: Key topics on AML at EHA 2017
Uploaded: 2017-08-25T11:15:55.000Z
Duration: 2 min 34 s
Description: Oliver Ottmann, MD, FRCPath from Cardiff University, Cardiff, UK gives us an overview of four major topics covered at the 2017 European Hematology Association (EHA) annual congress in Madrid, Spain regarding acute myeloid leukemia (AML). Prof. Ottmann talks to us about the impact that these topics, including minimal residual disease analysis, will have in the field of AML research and treatment.

Oliver Ottmann • 25 Aug 2017

EHA 2017

Acute Myeloid Leukemia

Oliver Ottmann, MD, FRCPath from Cardiff University, Cardiff, UK gives us an overview of four major topics covered at the 2017 European Hematology Association (EHA) annual congress in Madrid, Spain regarding acute myeloid leukemia (AML). Prof. Ottmann talks to us about the impact that these topics, including minimal residual disease analysis, will have in the field of AML research and treatment.